diffuse scleroderma
Information
- Disease name
- diffuse scleroderma
- Disease ID
- DOID:1580
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01538719 | Completed | Phase 1/Phase 2 | IL1-TRAP, Rilonacept, in Systemic Sclerosis | December 2011 | August 11, 2017 |
| NCT01881529 | Completed | A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma | April 2013 | March 2014 | |
| NCT04837131 | Terminated | Phase 2 | A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients | April 28, 2021 | February 23, 2024 |
| NCT01785056 | Unknown status | N/A | IVIG Treatment in Systemic Sclerosis | April 2013 | January 2019 |
- Disase is a (Disease Ontology)
- DOID:418
- Cross Reference ID (Disease Ontology)
- MESH:D045743
- Cross Reference ID (Disease Ontology)
- NCI:C116791
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:128460000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1258104
- Exact Synonym (Disease Ontology)
- diffuse systemic sclerosis
- Exact Synonym (Disease Ontology)
- systemic sclerosis, diffuse